Viyash Scientific Limited (VIYASH) — Announcement | 8 June 2026

StockFin.ai

Try Free

📢 Key Event
Viyash Scientific acquires BioForLife Italia for ₹188 crore to expand European pet care presence

🔮 What's Next
Q2 FY27

💡 Investor Takeaway
This acquisition strengthens Viyash's European footprint and growth potential in the high-demand companion animal health market.

Viyash Scientific announced its acquisition of Italy's BioForLife Italia S.r.l. for approximately ₹188 crore to expand its European companion animal health business, with the deal expected to close in Q2 FY27 and enhance its global pet care growth strategy.

📄 View Original Announcement (PDF)

📊 Stock Analysis — VIYASH ✨ Ask AI About This

About Viyash Scientific Limited (VIYASH)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹9,809.42 Cr P/E: 488.1

View full VIYASH stock details →

📡 Get AI alerts when VIYASH files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track VIYASH — Free

💡 Ask AI about this filing

"How does this affect VIYASH margins?" "Compare with last quarter results" "What should investors watch for?"

Ask AI Free →

📊 More VIYASH filings

See all VIYASH filings →

🔥 Also filed on 8 June 2026

RBLBANK RBL Bank Limited Insider Trading LEMONTREE Lemon Tree Hotels Limited Announcement SEDEMAC SEDEMAC Mechatronics Limited Announcement SURAJEST Suraj Estate Developers Limited Insider Trading STEELCAS Steelcast Limited Financial Results FINOPB Fino Payments Bank Limited Insider Trading

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

📡 Get AI alerts when VIYASH files new disclosures

Track VIYASH filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track VIYASH — Free

Free account · 2 AI queries/day